What Do Drug Monopolies Cost Consumers in Developing Countries?

11 Pages Posted: 24 Dec 2011

See all articles by Rebecca Hellerstein

Rebecca Hellerstein

Federal Reserve Bank of New York; Macro Labs

Date Written: December 1, 2011

Abstract

This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Keywords: Intellectual property rights, international price discrimination, TRIPS agreement, pharmaceutical industry, markups

JEL Classification: D4, F13, L1, L65, O34

Suggested Citation

Hellerstein, Rebecca and Hellerstein, Rebecca, What Do Drug Monopolies Cost Consumers in Developing Countries? (December 1, 2011). FRB of New York Staff Report No. 530, Available at SSRN: https://ssrn.com/abstract=1976372 or http://dx.doi.org/10.2139/ssrn.1976372

Federal Reserve Bank of New York ( email )

33 Liberty Street
New York, NY 10045
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
81
Abstract Views
720
Rank
547,134
PlumX Metrics